“a decreasing trend”

Additionally, we detected a small increasing trend change in the percentage of participants reporting to be mentally unhealthy (beta: 0.11, SE: 0.04, p-value = 0.002), a decreasing trend change in medication use for depression and/or anxiety (beta: −0.31, SE 0.12, p = 0.01), as well as differential trend changes in mental healthcare use (medium versus low social support, beta: −0.31; SE: 0.15; p-value = 0.04; non-Dutch with a LMIC background versus Dutch origin, beta: 0.67, SE: 0.25, p = 0.01).

The trend showed a decreasing trend (86.26% in 2013 vs. 66.73% in 2018; P < 0.01).

3.5 Serum health indices The serum health indices ( Table 7 ) have shown that TG, TC, CRR, AC, and AIP depicted a decreasing trend ( P < 0.01) from treatment T 1 to T 6 .

vWF and CD31 gene expression significantly increased with the increase of HB scaffold pore size going from 300 to 1,000 μm, while VE-cadherin gene expression showed a decreasing trend (ANOVA, p < 0.01).

The inhibition was dose-dependent and exhibited a decreasing trend along with a serum dilution increase ( F = 198.787, P < 0.01).

The rate of new cases with GPD II showed a decreasing trend between 2007-2015 (APC -5.9%, p <0.01) and considering the whole period of analysis (AAPC -3.1%, p <0.01).

Mean clavicular length showed a decreasing trend with increasing OA scores ( p = 0.01).

IL-1β expression tended to be higher at 3 dpi in Groups 2 and 3, whereas it showed a decreasing trend over time in the other groups ( p < 0.01) ( Figure 6D ).

A decreasing trend was observed for theophylline ( P = .01) (Table 1 ).

In BA1-BA3 hydrogel preparations ( Figure 2 a), a decreasing trend in swelling ratio (31.72–20.18) at pH 7.4 was observed with the increase in crosslinker (MBA) contents ( p -value < 0.01).

There was an increasing trend of having missing teeth ( p = 0.03) as people aged and a decreasing trend in the number of filled teeth ( p < 0.01).

The mRNA expressions of E2F and ESR1 were positively associated with FOXM1 , significantly increasing from LPAs to SPAs (Jonckheere-Terpstra test, P<0.01 Figure 2H,I ), while FOXO3A showed a decreasing trend (Jonckheere-Terpstra test, P<0.01, Figure 2J ).

Between the 1920s and the 1970s, a decreasing trend was seen (p<0.01, Figure 4 ).

In Italy, there was a decreasing trend up to April 2020 for prostate cancer (WPC: –15.9, 95% CI: –20.9; –10.6; p < 0.01), followed by a spectacular and important revival of interest (WPC: 42.4, 95% CI: –34.7; 210.4; p < 0.01).

Log 10 (hepcidin) showed a decreasing trend over time, with significant differences on Day 2 and all time points thereafter ( p < 0.01 on Days 2, 4, 7, 11, 14, 21, and 28 vs.

Between sessions one and three, all of the three techniques showed a decreasing trend of SpO 2 scores, with the exception of the pharmacological management of ADHD children (p<0.01) indicating that the uncontrollable ADHD children feel less anxious than in the other two approaches.

Compared with the DB group, the mice in the IO group showed a decreasing trend in blood glucose and AUC at each time point, including an evident decrease in blood glucose level at 30 min ( p < 0.01), a remarkable decrease at 120 min ( p < 0.05) and restored basal level ( Figures 1B, C ). 3.3.

A decreasing trend in ΣPAH concentrations was observed in Shenyang in the winter (statistical significance, p ≤ 0.01) and in Beijing in the summer, with a temporal increase in the winter of 2010.

The average dose per prescription per month (18.27–19.21 mg before the publication of the safety letter and 15.39–16.93 mg after the publication of safety letter) followed a decreasing trend before the safety letter (TIME1: −0.02, p-value <0.01).

A decreasing trend in cystatin B protein level (endogenous inhibitor of CTSL) was observed in the AD brain samples ( n = 3, p < 0.01) (Figure S5 D,E).

For body weight, the mean BMI values were 23.6 ± 3.2 kg/m 2 (95% CI: 22.7–24.5), 22.8 ± 2.9 kg/m 2 (95% CI: 21.9–23.7), and 21.5 ± 3.1 kg/m 2 (95% CI: 20.4–22.6) in the NG, MIG, and MOG, respectively, demonstrating a decreasing trend with worsening liver function impairment ( F = 7.25, P < 0.01).

Interestingly, a decreasing trend was observed in lean mass of AfperFit group from baseline to the end of treatment ( p <0.01).

It suggested that the RBCm@AuNPs-CP nanocomposites constructed significantly inhibited the growth of tumors, furthermore, the tumors showed a decreasing trend, which was 0.5 times than initial tumor size on the 14th day of treatment ( P < 0.01).

In the GG, the scores for happiness, appetite, hygiene, general health and owner pain showed an increasing trend starting from D2 ( P < 0.01); the mobility score decreased at D1 ( P < 0.01), followed by an increase at D3 ( P < 0.01), and the vet pain score exhibited a decreasing trend at D1 ( P < 0.01), followed by an increase starting from D2 ( P < 0.01).

In general terms (in both ZnO/PLA and ZnO@PDA/PLA composites), there is a decreasing trend in total bacterial growth (p < 0.05 when each composite is compared with pure PLA) and, in the case of 3% ZnO/PLA, the difference is statistically highly significant (p < 0.01).